With AWS the cloud of choice, Gilead leverages AWS machine learning and analytics to better educate clinical trial design and drive data-driven decision-making while prioritizing patient privacy and safety
Gilead is also transforming its enterprise resource planning workloads on AWS to implement SAP S / 4HANA in its global business
Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced that Gilead Sciences, Inc., a biopharmaceutical company that Developed innovative d**** to prevent and treat life-threatening diseases, selected by AWS as their preferred cloud provider. preferred cloud provider. With AWS innovations and the help of AWS experts and partners in healthcare and life sciences, Gilead brings its data scientists the latest advances in machine learning and analytics. These skills drive data-driven decision-making across the enterprise – from biomarker discovery to manufacturing to recruitment for clinical trials – and provide insights that can help Gilead refine its drug pipeline. The company also relies on AWS to host all of the workloads for its Enterprise Resource Planning (ERP) transformation project to implement SAP S / 4HANA.
“AWS delivers the security and privacy that healthcare and life sciences organizations need, as well as the expertise, breadth and depth of services they can rely on to create transformative health solutions that improve health and wellbeing.”
“With AWS as our preferred cloud provider, our researchers can leverage the AWS service portfolio to gain the insight, flexibility, and security needed to rapidly deliver new d****, and not just treat individuals based on their individual needs of the disease, “said Marc Berson, senior vice president and chief information officer, Gilead. “The performance, infrastructure and size of AWS are the foundations on which we will complete our ERP transformation and become a more efficient, agile, secure and data-driven company in the cloud.”
Top iTechnology Networking News: Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
Gilead is redesigning its bioinformatics computing infrastructure in the world’s leading cloud. Leveraging the computational, machine learning, and database capabilities of AWS will support the analysis and integration of various genomics, imaging, and experimental datasets to aid breakthroughs in Gilead’s diagnosis and treatment of disease. For example, by securely analyzing anonymized patient genomic data on a large scale on AWS to uncover patterns, Gilead can gain insights into how people with cancer respond to existing therapeutic options, potentially accelerating the discovery of new treatments.
In addition, Gilead uses AWS in its IT organization to host all workloads for its ERP transformation project to implement SAP S / 4HANA. These systems support business-critical processes in areas such as supply chain, finance, operations and commercial sales in all therapeutic areas and business areas. Running these processes on AWS forms the basis for Gilead’s implementation of SAP S / 4HANA. It also helps the company shorten hardware update cycles, increase test and deployment agility, and gain visibility to improve business planning.
This is Gilead’s first implementation of production-scale ERP systems in the cloud, and AWS provides the company’s IT transformation team with a scalable, secure, and high-performing infrastructure. Working with AWS, Gilead will integrate its SAP environments with a wide range of advanced AWS technologies in areas such as analytics and machine learning to uncover business value and drive innovation. In the future, the company will use a variety of Amazon Elastic Compute Cloud instance types (Amazon EC2) as the basis of its new cloud-based SAP environment with AWS. This includes X1 and X1e instances, which are designed for high-performance databases, in-memory databases, and other storage-intensive enterprise applications to run ERP workloads more efficiently.
Additionally, Gilead has moved more than 50% of its data center space to AWS over the past 12 months through an accelerated cloud migration program with AWS Professional Services. The company also plans to migrate hundreds of applications to AWS, including critical applications that support industry best practice guidelines and regulations (GxP) in areas such as drug manufacturing, storage, and distribution. As a result, Gilead is accelerating its plans to upgrade its IT operations with AWS, while avoiding the up-front costs of upgrading hardware and the ongoing costs of running an always-on, local IT landscape that is provided for peak loads. As an additional element of the migration, the company is building an automated disaster recovery landscape in AWS. This enables Gilead IT to optimize and scale its disaster recovery processes in the cloud to increase resilience.
Top iTechnology AIOps News: Adjuvare Launches Real-Time Remote Patient Monitoring Combining AI Mobile Technology and Virtual Acute-Care Services
With the help of AWS Professional Services and AWS Healthcare and Life Sciences experts, Gilead’s research and development teams are looking for opportunities to innovate in the cloud. You are pursuing an agile product development approach that uses microservices to optimize and automate operational processes throughout the company, and you are building new data architectures to make it easier to gain new insights. Through the collaboration, Gilead aims to transform priority areas such as clinical program and study design, patient experience and the centralized statistical adaptive monitoring that helps Gilead quickly identify and resolve potential problems related to clinical trial management.
Gilead was also one of the early adopters of AWS for Health , a suite of curated AWS services and AWS Partner Network (APN) solutions that are used today by thousands of healthcare and life sciences customers worldwide. AWS for Health provides proven and easily accessible features to help companies accelerate the pace of innovation, unlock the potential of health data, and develop more personalized approaches to therapeutic development and care in 16 critical solution areas in healthcare, genomics, and biopharma.
“Gilead leverages the proven performance of the world’s leading cloud to deliver innovative, scalable and high-performance therapies for diseases such as HIV and cancer, as well as advanced standards for precision medicine. By streamlining IT operations with AWS and leveraging our AWS for Health offerings, Gilead has the opportunity to continually refine its approach to clinical trials, drug development, manufacturing and distribution, ”said Matt Garman, senior vice president of sales and marketing at Amazon Web Services, Inc. “AWS delivers the security and privacy that healthcare and life sciences organizations need, as well as the expertise, breadth and depth of services they can rely on to create transformative healthcare solutions.
Top iTechnology IT and DevOps News: Vertical Relevance Achieves AWS DevOps Competency Status
[To share your insights with us, please write to sghosh@martechseries.com]
